FAPI PET/CT Imaging-An Updated Review.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

1. Diagnostic utility of FDG and FAPI PET imaging in crohn's disease: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2026
   Pooled it
2. Therapeutic potential of FAPI RLT in oncology: A systematic review.Theranostics · 2025
   Pooled it
3. Cancer theranostics.Nature reviews. Cancer · 2026
   Review
4. Tracking Active Fibroblast-Mediated Tissue Remodelling in Cardiomyopathies: Translational Insights from FAPI PET Imaging.International journal of molecular sciences · 2026
   Review
5. Molecular imaging and radionuclide therapy · 2026
   Article
6. Diagnostic Performance of ⁶⁸Ga-FAPI PET/CT, ¹⁸F-FDG PET/CT, and Breast MRI for Assessing Tumor Extent and Axillary Metastasis in Breast Cancer: A Histopathology-Referenced Retrospective Study.European journal of nuclear medicine and molecular imaging · 2026
   Article
7. World journal of nuclear medicine · 2026
   Article
8. Fibroblast Activation Protein Inhibitor Positron Emission Tomography Imaging in Atrial Fibrillation: Current Evidence and Future Perspectives.Reviews in cardiovascular medicine · 2026
   Review
9. The Evolution of FAP-Targeted CAR T-Cell Therapy in Solid Tumors: From Immunotherapy to Immunotheranostic Applications.International journal of molecular sciences · 2026
   Review
10. [European journal of nuclear medicine and molecular imaging · 2026
    Article
11. FAPI: a solution to all, what about NENs?EJNMMI reports · 2026
    Review
12. PET Imaging of Cardiac Inflammation in Viral Myocarditis Using a DPP4-Targeted Probe.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
13. Clinical and research applications of fibroblast activation protein-α inhibitor tracers: a review.The British journal of radiology · 2026
    Review
14. Molecular, Biochemical, and Bioimaging Markers of MEN Syndromes.Genes · 2026
    Review
15. Comparative Insights intoMolecular imaging and radionuclide therapy · 2026
    Article
16. BMC pulmonary medicine · 2026
    Observational
17. Noninvasive tracking of myocardial fibrosis in pressure-overload heart failure with [EJNMMI research · 2026
    Article
18. Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications.Diagnostics (Basel, Switzerland) · 2026
    Review
19. Fibroblast activation protein inhibitor (FAPI) PET imaging in pulmonary fibrosis: pathophysiology, clinical utility, and emerging theranostic applications.Respiratory research · 2026
    Review
20. Combined antitumor activity of [EJNMMI research · 2026
    Article

9 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 3 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as